SNDL (SNDL) Competitors $2.56 +0.07 (+2.60%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. ACB, CGC, CRON, OGI, TLRY, ALVO, CPRX, CNTA, TARS, and MLYSShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Alvotech (ALVO), Catalyst Pharmaceuticals (CPRX), Centessa Pharmaceuticals (CNTA), Tarsus Pharmaceuticals (TARS), and Mineralys Therapeutics (MLYS). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global Tilray Brands Alvotech Catalyst Pharmaceuticals Centessa Pharmaceuticals Tarsus Pharmaceuticals Mineralys Therapeutics SNDL (NASDAQ:SNDL) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations. Which has more volatility & risk, SNDL or ACB? SNDL has a beta of 3.92, suggesting that its share price is 292% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Which has stronger earnings and valuation, SNDL or ACB? Aurora Cannabis has lower revenue, but higher earnings than SNDL. Aurora Cannabis is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$671.81M1.00-$69.18M-$0.27-9.43Aurora Cannabis$246.72M1.19$1.63M-$0.19-27.29 Is SNDL or ACB more profitable? Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.49% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets SNDL-10.38% -8.58% -7.23% Aurora Cannabis -5.66%-1.49%-1.06% Do analysts rate SNDL or ACB? SNDL presently has a consensus price target of $4.50, suggesting a potential upside of 76.82%. Given SNDL's higher probable upside, research analysts clearly believe SNDL is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Aurora Cannabis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media favor SNDL or ACB? In the previous week, SNDL and SNDL both had 2 articles in the media. Aurora Cannabis' average media sentiment score of 0.64 beat SNDL's score of 0.61 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in SNDL or ACB? 47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAurora Cannabis beats SNDL on 10 of the 14 factors compared between the two stocks. Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$668.78M$10.60B$5.79B$10.36BDividend YieldN/A1.88%5.86%4.62%P/E Ratio-9.4321.7176.8626.91Price / Sales1.0031.81450.9189.68Price / CashN/A24.5537.2260.63Price / Book0.813.4413.756.37Net Income-$69.18M$210.63M$3.29B$271.38M7 Day Performance6.49%-0.34%0.53%2.11%1 Month Performance17.82%0.97%4.89%7.56%1 Year Performance19.48%-8.94%83.74%31.10% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL3.6985 of 5 stars$2.57+2.6%$4.50+75.4%+13.1%$674.03M$671.81M-9.502,516ACBAurora Cannabis0.4046 of 5 stars$4.84-1.4%N/A-16.3%$273.22M$246.72M-25.471,130News CoverageCGCCanopy Growth0.9893 of 5 stars$1.35-7.5%N/A-72.2%$323.80M$225.65M-0.453,150Positive NewsOptions VolumeCRONCronos Group1.7337 of 5 stars$2.48-0.8%N/A+14.2%$949.57M$117.61M49.60450OGIOrganigram Global0.7272 of 5 stars$1.64-0.6%N/A-6.3%$219.84M$117.47M32.81860TLRYTilray Brands3.0517 of 5 stars$1.12-5.9%$1.94+73.0%-34.3%$1.23B$821.31M-0.482,842ALVOAlvotech3.2777 of 5 stars$8.16-2.0%$14.00+71.6%-28.0%$2.46B$560.10M35.481,032Short Interest ↓CPRXCatalyst Pharmaceuticals4.9612 of 5 stars$20.08-1.0%$33.20+65.3%-2.1%$2.46B$491.73M12.1780Positive NewsCNTACentessa Pharmaceuticals3.1734 of 5 stars$18.03+14.6%$31.45+74.5%+34.2%$2.41B$15M-10.07200Insider TradeHigh Trading VolumeTARSTarsus Pharmaceuticals2.6202 of 5 stars$56.89-1.3%$66.67+17.2%+66.5%$2.40B$182.95M-24.4250Positive NewsMLYSMineralys Therapeutics2.4322 of 5 stars$35.93+3.2%$36.60+1.9%+211.3%$2.38BN/A-10.0928Insider Trade Related Companies and Tools Related Companies Aurora Cannabis Alternatives Canopy Growth Alternatives Cronos Group Alternatives Organigram Global Alternatives Tilray Brands Alternatives Alvotech Alternatives Catalyst Pharmaceuticals Alternatives Centessa Pharmaceuticals Alternatives Tarsus Pharmaceuticals Alternatives Mineralys Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhy Peter Thiel Hid Gold in a VaultSilicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions...Golden Portfolio | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNDL Stock Alerts